Drug-induced liver injury (DILI): Current status and future directions for drug development and the post-market setting

dc.contributor.authorCouncil for International Organizations of Medical Sciences (CIOMS)
dc.date.accessioned2020-06-19T11:28:10Z
dc.date.available2020-06-19T11:28:10Z
dc.date.issued2020
dc.identifier.urihttp://hdl.handle.net/10062/68140
dc.languageinglise keeleset
dc.language.isoenget
dc.publisherGeneva. Council for International Organizations of Medical Sciences (CIOMS)et
dc.rightsopenAccesset
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.otherfarmakoloogiaet
dc.subject.othergastroenteroloogiaet
dc.subject.otherhepatoloogiaet
dc.subject.othermaksakahjustusedet
dc.subject.otherravimidet
dc.subject.othertervishoiukorralduset
dc.subject.otherravimite kõrvaltoimedet
dc.titleDrug-induced liver injury (DILI): Current status and future directions for drug development and the post-market settinget
dc.typeBooket

Files

Original bundle
Now showing 1 - 3 of 3
No Thumbnail Available
Name:
CIOMS_DILI_Web_16Jun2020.pdf
Size:
3.13 MB
Format:
Adobe Portable Document Format
Description:
No Thumbnail Available
Name:
CIOMS_DILI_SupplementalAppendices.pdf
Size:
1.37 MB
Format:
Adobe Portable Document Format
Description:
Supplemental Appendices
No Thumbnail Available
Name:
draft_crf_dili_8Jun2020.xlsx
Size:
46.77 KB
Format:
Microsoft Excel XML
Description:
Case report form
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.67 KB
Format:
Item-specific license agreed upon to submission
Description: